175 related articles for article (PubMed ID: 34265330)
1. Human Desmocollin 3‒Specific IgG Antibodies Are Pathogenic in a Humanized HLA Class II Transgenic Mouse Model of Pemphigus.
Hudemann C; Maglie R; Llamazares-Prada M; Beckert B; Didona D; Tikkanen R; Schmitt T; Hashimoto T; Waschke J; Hertl M; Eming R
J Invest Dermatol; 2022 Mar; 142(3 Pt B):915-923.e3. PubMed ID: 34265330
[TBL] [Abstract][Full Text] [Related]
2. IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion.
Rafei D; Müller R; Ishii N; Llamazares M; Hashimoto T; Hertl M; Eming R
Am J Pathol; 2011 Feb; 178(2):718-23. PubMed ID: 21281804
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
[TBL] [Abstract][Full Text] [Related]
4. Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris.
Schmidt T; Willenborg S; Hünig T; Deeg CA; Sonderstrup G; Hertl M; Eming R
Exp Dermatol; 2016 Apr; 25(4):293-8. PubMed ID: 26661498
[TBL] [Abstract][Full Text] [Related]
5. Development of a Desmocollin-3 Active Mouse Model Recapitulating Human Atypical Pemphigus.
Lotti R; Atene CG; Marconi A; Di Rocco G; Reggiani Bonetti L; Zanocco Marani T; Pincelli C
Front Immunol; 2019; 10():1387. PubMed ID: 31275323
[TBL] [Abstract][Full Text] [Related]
6. Pemphigus Vulgaris and Foliaceus IgG Autoantibodies Directly Block Heterophilic Transinteraction between Desmoglein and Desmocollin.
Ishii K; Yoshida K; Stanley JR; Yamagami J; Amagai M; Ishiko A
J Invest Dermatol; 2020 Oct; 140(10):1919-1926.e7. PubMed ID: 32142800
[TBL] [Abstract][Full Text] [Related]
7. Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris.
Chernyavsky A; Amber KT; Agnoletti AF; Wang C; Grando SA
J Biol Chem; 2019 Mar; 294(12):4520-4528. PubMed ID: 30692201
[TBL] [Abstract][Full Text] [Related]
8. Atypical pemphigus with immunoglobulin G autoantibodies against desmoglein 3 and desmocollin 3.
Kamiya K; Aoyama Y; Wakashima C; Kudo T; Nakajima K; Sano S; Ishii N; Teye K; Hashimoto T; Iwatsuki K; Tokura Y
J Dermatol; 2016 Apr; 43(4):429-31. PubMed ID: 26331291
[TBL] [Abstract][Full Text] [Related]
9. The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient.
Ivars M; España A; Alzuguren P; Pelacho B; Lasarte JJ; López-Zabalza MJ
Br J Dermatol; 2020 May; 182(5):1194-1204. PubMed ID: 31370093
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against desmocollins in European patients with pemphigus.
Müller R; Heber B; Hashimoto T; Messer G; Müllegger R; Niedermeier A; Hertl M
Clin Exp Dermatol; 2009 Dec; 34(8):898-903. PubMed ID: 19456767
[TBL] [Abstract][Full Text] [Related]
11. Two cases of pemphigus vegetans with IgG anti-desmocollin 3 antibodies.
Saruta H; Ishii N; Teye K; Ono F; Ohyama B; Koga H; Ohata C; Furumura M; Tsuruta D; Hashimoto T
JAMA Dermatol; 2013 Oct; 149(10):1209-13. PubMed ID: 23946009
[TBL] [Abstract][Full Text] [Related]
12. Desmocollin 3-mediated binding is crucial for keratinocyte cohesion and is impaired in pemphigus.
Spindler V; Heupel WM; Efthymiadis A; Schmidt E; Eming R; Rankl C; Hinterdorfer P; Müller T; Drenckhahn D; Waschke J
J Biol Chem; 2009 Oct; 284(44):30556-64. PubMed ID: 19717567
[TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
Front Immunol; 2018; 9():1935. PubMed ID: 30233569
[TBL] [Abstract][Full Text] [Related]
14. Significance of anti-desmocollin autoantibodies in pemphigus.
Ishii N
J Dermatol; 2023 Feb; 50(2):132-139. PubMed ID: 36578135
[TBL] [Abstract][Full Text] [Related]
15. Pemphigus herpetiformis with IgA and IgG antibodies to desmoglein 1 and IgG antibodies to desmocollin 3.
Kozlowska A; Hashimoto T; Jarzabek-Chorzelska M; Amagai A; Nagata Y; Strasz Z; Jablonska S
J Am Acad Dermatol; 2003 Jan; 48(1):117-22. PubMed ID: 12522381
[TBL] [Abstract][Full Text] [Related]
16. Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus Vulgaris.
Didona D; Scarsella L; Hudemann C; Volkmann K; Zimmer CL; Beckert B; Tikkanen R; Korff V; Kühn K; Wienzek-Lischka S; Bein G; Di Zenzo G; Böhme J; Cunha T; Solimani F; Pieper J; Juratli HA; Göbel M; Schmidt T; Borradori L; Yazdi AS; Sitaru C; Garn H; Eming R; Fleischer S; Hertl M
J Invest Dermatol; 2024 Feb; 144(2):263-272.e8. PubMed ID: 37717934
[TBL] [Abstract][Full Text] [Related]
17. Mucosal pemphigus vulgaris anti-Dsg3 IgG is pathogenic to the oral mucosa of humanized Dsg3 mice.
Culton DA; McCray SK; Park M; Roberts JC; Li N; Zedek DC; Anhalt GJ; Cowley DO; Liu Z; Diaz LA
J Invest Dermatol; 2015 Jun; 135(6):1590-1597. PubMed ID: 25695683
[TBL] [Abstract][Full Text] [Related]
18. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis.
Oktarina DA; van der Wier G; Diercks GF; Jonkman MF; Pas HH
Br J Dermatol; 2011 Sep; 165(3):552-62. PubMed ID: 21692763
[TBL] [Abstract][Full Text] [Related]
19. A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants.
Lotti R; Atene CG; Zanfi ED; Bertesi M; Pincelli C; Zanocco-Marani T
Biology (Basel); 2023 May; 12(5):. PubMed ID: 37237515
[No Abstract] [Full Text] [Related]
20. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
